RGS10 and RGS18 differentially limit platelet activation...

THROMBOSIS AND HEMOSTASIS| OCTOBER 8, 2020

RGS10 and RGS18 differentially limit platelet activation, promote platelet production, and prolong platelet survival

Daniel DeHelian, Shuchi Gupta, Jie Wu, Chelsea Thorsheim, Brian Estevez, Matthew Cooper, Kelly Litts, Melissa M. Lee-Sundlov, Karin M. Hoffmeister, Mortimer Poncz, Peisong Ma, Lawrence F. Brass

Blood (2020) 136 (15): 1773–1782.

https://doi.org/10.1182/blood.2019003251

Key Points

RGS10 and RGS18 cooperate to restrain unnecessary platelet activation, while RGS18 promotes platelet production.

Deleting RGS10 and RGS18 results in platelet preactivation, reduced survival, thrombocytopenia, and occlusive hemostatic plugs.

Abstract

G protein–coupled receptors are critical mediators of platelet activation whose signaling can be modulated by members of the regulator of G protein signaling (RGS) family. The 2 most abundant RGS proteins in human and mouse platelets are RGS10 and RGS18. While each has been studied individually, critical questions remain about the overall impact of this mode of regulation in platelets. Here, we report that mice missing both proteins show reduced platelet survival and a 40% decrease in platelet count that can be partially reversed with aspirin and a P2Y12 antagonist. Their platelets have increased basal (TREM)-like transcript-1 expression, a leftward shift in the dose/response for a thrombin receptor–activating peptide, an increased maximum response to adenosine 5′-diphosphate and TxA2, and a greatly exaggerated response to penetrating injuries in vivo. Neither of the individual knockouts displays this constellation of findings. RGS10−/− platelets have an enhanced response to agonists in vitro, but platelet count and survival are normal. RGS18−/− mice have a 15% reduction in platelet count that is not affected by antiplatelet agents, nearly normal responses to platelet agonists, and normal platelet survival. Megakaryocyte number and ploidy are normal in all 3 mouse lines, but platelet recovery from severe acute thrombocytopenia is slower in RGS18−/− and RGS10−/−18−/− mice. Collectively, these results show that RGS10 and RGS18 have complementary roles in platelets. Removing both at the same time discloses the extent to which this regulatory mechanism normally controls platelet reactivity in vivo, modulates the hemostatic response to injury, promotes platelet production, and prolongs platelet survival.

Subjects:

Platelets and Thrombopoiesis, Thrombosis and Hemostasis

REFERENCES

1.Druey KM, Blumer KJ, Kang VH, Kehrl JH. Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature. 1996;379(6567):742-746.

2.Koelle MR, Horvitz HR. EGL-10 regulates G protein signaling in the C. elegans nervous system and shares a conserved domain with many mammalian proteins. Cell. 1996;84(1):115-125.

3.Tesmer JJ, Berman DM, Gilman AG, Sprang SR. Structure of RGS4 bound to AlF4–activated G(i alpha1): stabilization of the transition state for GTP hydrolysis. Cell. 1997;89(2):251-261.

4.Watson N, Linder ME, Druey KM, Kehrl JH, Blumer KJ. RGS family members: GTPase-activating proteins for heterotrimeric G-protein α-subunits. Nature. 1996;383(6596):172-175.

5.Burkhart JM, Vaudel M, Gambaryan S, et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood. 2012;120(15):e73-e82.

6.Rowley JW, Oler AJ, Tolley ND, et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes [published correction appears in Blood. 2011;118(14):e101-e111]. Blood. 2011;118(14):3760-3761.

7.Zeiler M, Moser M, Mann M. Copy number analysis of the murine platelet proteome spanning the complete abundance range. Mol Cell Proteomics. 2014;13(12):3435-3445.

8.Gagnon AW, Murray DL, Leadley RJ. Cloning and characterization of a novel regulator of G protein signalling in human platelets. Cell Signal. 2002;14(7):595-606.

9.Nagata Y, Oda M, Nakata H, Shozaki Y, Kozasa T, Todokoro K. A novel regulator of G-protein signaling bearing GAP activity for Galphai and Galphaq in megakaryocytes. Blood. 2001;97(10):3051-3060.

10.Park IK, Klug CA, Li K, et al. Molecular cloning and characterization of a novel regulator of G-protein signaling from mouse hematopoietic stem cells. J Biol Chem. 2001;276(2):915-923.

11.Yowe D, Weich N, Prabhudas M, et al. RGS18 is a myeloerythroid lineage-specific regulator of G-protein-signalling molecule highly expressed in megakaryocytes. Biochem J. 2001;359(Pt 1):109-118.

12.Alqinyah M, Maganti N, Ali MW, et al. Regulator of G-protein signaling 10 (RGS10) expression is transcriptionally silenced in activated microglia by histone deacetylase activity. Mol Pharmacol. 2017;91(3):197-207.

13.García-Bernal D, Dios-Esponera A, Sotillo-Mallo E, García-Verdugo R, Arellano-Sánchez N, Teixidó J. RGS10 restricts upregulation by chemokines of T cell adhesion mediated by α4β1 and αLβ2 integrins. J Immunol. 2011;187(3):1264-1272.

14.Hooks SB, Callihan P, Altman MK, Hurst JH, Ali MW, Murph MM. Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells. Mol Cancer. 2010;9(1):289.

15.Miao R, Lu Y, Xing X, et al. Regulator of G-protein signaling 10 negatively regulates cardiac remodeling by blocking mitogen-activated protein kinase-extracellular signal-regulated protein kinase 1/2 signaling. Hypertension. 2016;67(1):86-98.

16.Yang S, Li Y-PP. RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation. Genes Dev. 2007;21(14):1803-1816.

17.Alshbool FZ, Karim ZA, Vemana HP, Conlon C, Lin OA, Khasawneh FT. The regulator of G-protein signaling 18 regulates platelet aggregation, hemostasis and thrombosis. Biochem Biophys Res Commun. 2015;462(4):378-382.

18.Delesque-Touchard N, Pendaries C, Volle-Challier C, et al. Regulator of G-protein signaling 18 controls both platelet generation and function. PLoS One. 2014;9(11):e113215.

19.Hensch NR, Karim ZA, Druey KM, Tansey MGG, Khasawneh FT. RGS10 Negatively Regulates Platelet Activation and Thrombogenesis. PLoS One. 2016;11(11):e0165984.

20.Ma P, Gupta S, Sampietro S, et al. RGS10 shapes the hemostatic response to injury through its differential effects on intracellular signaling by platelet agonists. Blood Adv. 2018;2(16):2145-2155.

21.Signarvic RS, Cierniewska A, Stalker TJ, et al. RGS/Gi2alpha interactions modulate platelet accumulation and thrombus formation at sites of vascular injury. Blood. 2010;116(26):6092-6100.

22.Yang J, Wu J, Jiang H, et al. Signaling through Gi family members in platelets. Redundancy and specificity in the regulation of adenylyl cyclase and other effectors. J Biol Chem. 2002;277(48):46035-46042.

23.Henao-Mejia J, Williams A, Rongvaux A, Stein J, Hughes C, Flavell RA. Generation of genetically modified mice using the CRISPR-Cas9 genome-editing system. Cold Spring Harb Protoc. 2016;2016(2):t090704.

24.Stalker TJ, Traxler EA, Wu J, et al. Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood. 2013;121(10):1875-1885.

25.Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginsberg MH, Furie B. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein. J Clin Invest. 1986;78(1):130-137.

26.Hsu-Lin S, Berman CL, Furie BC, August D, Furie B. A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets. J Biol Chem. 1984;259(14):9121-9126.

27.Bertoni A, Tadokoro S, Eto K, et al. Relationships between Rap1b, affinity modulation of integrin α IIbbeta 3, and the actin cytoskeleton. J Biol Chem. 2002;277(28):25715-25721.

28.Shen J, Sampietro S, Wu J, et al. Coordination of platelet agonist signaling during the hemostatic response in vivo. Blood Adv. 2017;1(27):2767-2775.

29.Da Q, Derry PJ, Lam FW, Rumbaut RE. Fluorescent labeling of endogenous platelets for intravital microscopy: Effects on platelet function. Microcirculation. 2018;25(6):e12457.

30.Lee LG, Chen CH, Chiu LA. Thiazole orange: a new dye for reticulocyte analysis. Cytometry. 1986;7(6):508-517.

31.Smith CW, Raslan Z, Parfitt L, et al. TREM-like transcript 1: a more sensitive marker of platelet activation than P-selectin in humans and mice. Blood Adv. 2018;2(16):2072-2078.

32.Washington AV, Schubert RL, Quigley L, et al. A TREM family member, TLT-1, is found exclusively in the α-granules of megakaryocytes and platelets. Blood. 2004;104(4):1042-1047.

33.Yang J, Wu J, Kowalska MA, et al. Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc Natl Acad Sci USA. 2000;97(18):9984-9989.

34.Lanza F, Beretz A, Stierlé A, Hanau D, Kubina M, Cazenave JP. Epinephrine potentiates human platelet activation but is not an aggregating agent. Am J Physiol. 1988;255(6 Pt 2):H1276-H1288.

35.Grozovsky R, Begonja AJ, Liu K, et al. The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling. Nat Med. 2015;21(1):47-54.

36.Green ED, Brodbeck RM, Baenziger JU. Lectin affinity high-performance liquid chromatography. Interactions of N-glycanase-released oligosaccharides with Ricinus communis agglutinin I and Ricinus communis agglutinin II. J Biol Chem. 1987;262(25):12030-12039.

37.Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994;84(5):1415-1420.

38.Zhang H, Nimmer PM, Tahir SK, et al. Bcl-2 family proteins are essential for platelet survival. Cell Death Differ. 2007;14(5):943-951.

39.Ma P, Cierniewska A, Signarvic R, et al. A newly identified complex of spinophilin and the tyrosine phosphatase, SHP-1, modulates platelet activation by regulating G protein-dependent signaling. Blood. 2012;119(8):1935-1945.

40.Zhao L, Liu J, He C, et al. Protein kinase A determines platelet life span and survival by regulating apoptosis. J Clin Invest. 2017;127(12):4338-4351.

41.Stefanini L, Paul DS, Robledo RF, et al. RASA3 is a critical inhibitor of RAP1-dependent platelet activation. J Clin Invest. 2015;125(4):1419-1432.

© 2020 by The American Society of Hematology

This program is developed by Focus Insight with the permission of American Society of Hematology, Inc. The content are excerpted from the journal Blood. Copyright © 2019 The American Society of Hematology. All rights reserved. 「American Society of Hematology」, 「ASH」 and the ASH Logo are registered trademarks of the American Society of Hematology.